Safety
GLP-1 dosing safety: mg, mL, and syringe units
A prescription may describe milligrams, a vial may list mg/mL, and a syringe may have unit markings. Confusing those measures can produce a serious dosing error.
Four different pieces of information
Milligrams describe how much medicine is prescribed. Concentration describes how many milligrams are in each milliliter of liquid. Milliliters describe the volume to draw up. Syringe units describe markings on a particular syringe and do not inherently identify a medicine dose.
The relationship depends on both the vial concentration and the syringe. A change in pharmacy, formulation, vial size, or concentration can change the required volume even if the prescribed milligrams stay the same. Never reuse old unit instructions without checking.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
What FDA has observed
FDA has reported dosing errors with compounded semaglutide, including cases requiring medical attention. Confusion about measuring a dose can occur for patients and healthcare professionals, particularly when a product is supplied in a multidose vial rather than a prepared pen.
These reports support asking for clear instructions, not making a universal internet conversion chart. Keep the prescription, vial label, syringe specification, and pharmacist's written directions together. Confirm the intended dose with a pharmacist before injecting if any of them disagree.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
What to request from the pharmacy
Ask the pharmacist to state the prescribed milligrams, the vial concentration, the exact volume, and the specific syringe markings to use. Request a demonstration if the device is unfamiliar. Check the beyond-use date, storage, and instructions after opening.
If the pharmacy changes your concentration, ask for new written instructions before using the vial. Do not transfer a pen's dose-selection behavior to a syringe or assume that a familiar vial appearance means the formula is unchanged.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
If an error may have occurred
Contact the prescriber, pharmacist, or local poison-control service promptly if the wrong dose may have been taken. Seek urgent care for severe symptoms such as persistent vomiting, fainting, severe abdominal pain, or inability to keep fluids down.
Record the product, concentration, amount drawn, and time of injection without taking another dose to correct the situation. Report suspected adverse events or quality problems through FDA MedWatch when appropriate.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
Sources and evidence
Sources checked October 2, 2026. Prescribing information supports medication facts; provider pages support advertised services. Offers and labels can change.